Related Experiment Video

Updated: May 30, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

[The development of international pediatric diabetes organizations]

Zvi Laron1

  • 1Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center of Israel, Petach Tiqva, Israel. laronz@clalit.org.il

Revue Medicale De Bruxelles
|August 5, 2011
PubMed

Insights

The International Society for Pediatric and Adolescent Diabetes (ISPAD) was founded in 1972 to address the specialized needs of children and adolescents with diabetes, improving their care and education globally.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Public Health

Context:

  • Historically, pediatric diabetes care was managed by adult diabetologists, not pediatricians.
  • A recognized need existed for a dedicated professional organization focused on pediatric and adolescent diabetes.
  • The early 1970s marked a critical period for establishing specialized care pathways.

Purpose:

  • To establish a dedicated international association for pediatric and adolescent diabetes.
  • To improve the care and education standards for young individuals with diabetes.
  • To foster collaboration among healthcare professionals specializing in pediatric diabetes.

Summary:

  • The International Study Group on Diabetes in Children and Adolescents (ISGD) was formed in 1972.
  • In 1993, ISGD was renamed the International Society for Pediatric and Adolescent Diabetes (ISPAD).
  • By 2009, ISPAD comprised 891 members from 89 countries, with its journal 'Pediatric Diabetes' holding an impact factor of 2.424.

Impact:

  • Facilitated the development of specialized pediatric diabetes care.
  • Enhanced global collaboration and knowledge sharing in the field.
  • Provided a platform for research and education through its dedicated journal.

More Related Videos

Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters08:09

Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters

Published on: May 18, 2014

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network09:54

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network

Published on: January 29, 2018

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...